Polymorphisms in xenobiotic metabolism-related genes in patients with hepatocellular carcinoma: a case–control study

References

• Boccia, S., et al., 2015. The effect of CYP, GST, and SULT polymorphisms and their interaction with smoking on the risk of hepatocellular carcinoma. Biomed research international, 2015, 179867.
   PubMed Web of Science ®Google Scholar
• Bray, F., et al., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68 (6), 394–424.
   PubMed Web of Science ®Google Scholar
• Chen, K.J., et al., 2014. GSTT1 null genotype contributes to hepatocellular carcinoma risk: a meta-analysis. Tumor biology, 35 (1), 213–218.
   PubMedGoogle Scholar
• Chen, Y.L., et al., 2010. Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma. BMC medical genetics, 11 (1), 46.
   PubMed Web of Science ®Google Scholar
• De Bruin, W.C., Wagenmans, M.J., and Peters, W.H., 2000. Expression of glutathione S-transferase alpha, P1-1 and T1-1 in the human gastrointestinal tract. Japanese journal of cancer research: Gann, 91 (3), 310–316.
   PubMedGoogle Scholar
• Duan, C.-Y., et al., 2014. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis. Tumour biology : the journal of the international society for oncodevelopmental biology and medicine, 35 (1), 659–666.,
   PubMedGoogle Scholar
• Fernandes, G.M., et al., 2016. CYP1A1, CYP2E1 and EPHX1 polymorphisms in sporadic colorectal neoplasms. World journal of gastroenterology, 22 (45), 9974–9983.
   PubMed Web of Science ®Google Scholar
• French, S.W., et al., 2012. Alcoholic liver disease – Hepatocellular carcinoma transformation. Journal of gastrointestinal oncology, 3 (3), 174–181.
   PubMedGoogle Scholar
• Fujiwara, N., et al., 2018. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. Journal of hepatology, 68 (3), 526–549.
   PubMed Web of Science ®Google Scholar
• Fujiwara, N., et al., 2014. Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation. European journal of gastroenterology and hepatology, 26 (9), 1039–1046.
   PubMed Web of Science ®Google Scholar
• Golan D.E., Tashjian A.H., Armstrong, E.J., and Armstrong, A.W. 2009. Princípios de farmacologia: a base fisiopatológica da farmacoterapia. Rio de Janeiro (RJ): Guanabara Koogan.
   Google Scholar
• Hagström, H., 2017. Alcohol, smoking and the liver disease patient. Best practice and research. clinical gastroenterology, 31 (5), 537–543.
   PubMed Web of Science ®Google Scholar
• Hao, W., and Storey, J.D., 2019. Extending tests of hardy-weinberg equilibrium to structured populations. Genetics, 213 (3), 759–770.
   PubMed Web of Science ®Google Scholar
• IARC. 2020. . World Cancer Report 2008, International Agency for Research on Cancer, France.
   Google Scholar
• INCA 2020. Câncer de fígado. Instituto Nacional do Câncer (INCA), Brazil.
   Google Scholar
• Ishii, T., et al., 1999. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax, 54 (8), 693–696.
   PubMed Web of Science ®Google Scholar
• Kang, H.W., et al., 2013. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients. European journal of cancer (Oxford, England : 1990), 49 (14), 3010–3019.
   PubMed Web of Science ®Google Scholar
• Knight, T.R., Choudhuri, S., and Klaassen, C.D., 2007. Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice. Toxicological sciences: an official journal of the society of toxicology, 100 (2), 513–524.
   PubMed Web of Science ®Google Scholar
• Li, S., et al., 2019. GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies. Cancer cell international, 19 (1), 76.
   PubMed Web of Science ®Google Scholar
• Lukanova, A., et al., 2014. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers? International journal of cancer, 134 (1), 164–173.
   PubMed Web of Science ®Google Scholar
• Ma, L., et al., 2014. Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World journal of gastroenterology, 20 (2), 333–345.
   PubMed Web of Science ®Google Scholar
• Maniglia, M.P., et al., 2020. Glutathione S-transferase polymorphisms in head and neck squamous cell carcinoma treated with chemotherapy and/or radiotherapy. Asian Pacific journal of cancer prevention : APJCP, 21 (6), 1637–1644.
   PubMedGoogle Scholar
• McGlynn, K.A., and London, W.T., 2005. Epidemiology and natural history of hepatocellular carcinoma. Best practice and research clinical gastroenterology, 19 (1), 3–23.
   PubMed Web of Science ®Google Scholar
• Miller, S.A., Dykes, D.D., and Polesky, H.F., 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research, 16 (3), 1215.
   PubMed Web of Science ®Google Scholar
• Munaka, M., et al., 2003. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. Journal of cancer research and clinical oncology, 129 (6), 355–360.
   PubMed Web of Science ®Google Scholar
• Pavanello, S., and Clonfero, E., 2000a. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutation research, 463 (3), 285–308.
   PubMed Web of Science ®Google Scholar
• Pavanello, S., and Clonfero, E., 2000b. Biomarkers of gentotoxic risk and metabolic polymorphism. La Medicina Del Lavoro, 91 (5), 431–469. [].
   PubMedGoogle Scholar
• Rodrigues-Fleming, G.H., et al., 2018. Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer. World journal of gastroenterology, 24 (39), 4462–4471.
   PubMed Web of Science ®Google Scholar
• Shen, Y.H., et al., 2014. Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk. Tumor biology, 35 (5), 4007–4015.
   PubMedGoogle Scholar
• Song, K., et al., 2012. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of hepatocellular carcinoma. Plos one, 7, e48924.
   PubMed Web of Science ®Google Scholar
• Subramaniam, S., Kelley, R.K., and Venook, A.P., 2013. A review of hepatocellular carcinoma (HCC) staging systems. Chinese clinical oncology, 2 (4), 33.
   PubMedGoogle Scholar
• Tang, Z.H., et al., 2014. Glutathione-S-transferase polymorphisms (GSTM1, GSTT1 and GSTP1) and acute leukemia risk in Asians: a meta-analysis. Asian Pacific journal of cancer prevention, 15 (5), 2075–2081.
   PubMedGoogle Scholar
• Tunissiolli, N.M., et al., 2017. Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pacific journal of cancer prevention : APJCP, 18 (4), 863–872.
   PubMedGoogle Scholar
• Tunissiolli, N.M., et al., 2018. Clinical, epidemiological and histopathological aspects in patients with hepatocellular carcinoma undergoing liver transplantation. Asian Pacific journal of cancer prevention, 19, 2795–2802.
   PubMedGoogle Scholar
• Václavíková, R., Hughes, D.J., and Souček, P., 2015. Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease. Gene, 571 (1), 1–8.
   PubMed Web of Science ®Google Scholar
• Vogl, F.D., et al., 2004. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer epidemiology, biomarkers and prevention : a publication of the american association for cancer research, cosponsored by the american society of preventive oncology, 13 (9), 1473–1479.
   Google Scholar
• Wang, D., et al., 2015. EPHX1 Tyr113His polymorphism contributes to hepatocellular carcinoma risk: evidfnce from a meta-analysis. Molekuliarnaia biologiia, 49 (2), 351–361.
   Web of Science ®Google Scholar
• Watson, M.A., et al., 1998. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis, 19 (2), 275–280.
   PubMed Web of Science ®Google Scholar
• White, D.L., et al., 2008. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. American journal of epidemiology, 167 (4), 377–389.
   PubMed Web of Science ®Google Scholar
• Xiao, Y., et al., 2012. Prioritizing cancer-related key miRNA-target interactions by integrative genomics. Nucleic acids research, 40 (16), 7653–7665.
   PubMed Web of Science ®Google Scholar
• Ye, Z., et al., 2006. Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. Plos medicine, 3 (4), e91.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., et al., 2013. Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma. Tumour biology, 34 (4), 2121–2126.
   PubMedGoogle Scholar
• Zheng, T., et al., 2002. Cigarette smoking, glutathione-s-transferase M1 and t1 genetic polymorphisms, and breast cancer risk (United States). Cancer causes and control : CCC, 13 (7), 637–645.
   PubMed Web of Science ®Google Scholar
• Zhong, J.H., et al., 2013. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma. PLoS One., 8 (2), e57064.
   PubMed Web of Science ®Google Scholar